Shih Alvin (CIK 0001610064)

Latest company ownership

TVTX - Travere Therapeutics, Inc.
Role: EVP of Research & Development
Shares held
158,334
Last filed at
Sep 2, 2016
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q2 2025Q4
Shares held
20,000
Last filed at
Sep 15, 2025
Confidence Score
58.4
2025Q4
Confidence Score History
2025Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 12, 2025 Sep 15, 2025 ZEVRA THERAPEUTICS, INC. Director Buy 95.0 +20,000 100.00% ✗ $157.8K
Sep 1, 2016 Sep 2, 2016 Travere Therapeutics, Inc. EVP of Research & Development Sell 32.5 -8,750 -5.24% ✓ $142.1K
Jun 1, 2016 Jun 2, 2016 Travere Therapeutics, Inc. EVP of Research & Development Sell 37.5 -8,750 -4.98% ✓ $155.3K
Mar 1, 2016 Mar 1, 2016 Travere Therapeutics, Inc. EVP of Research & Development Sell 37.5 -8,750 -4.74% ✓ $125.6K
Dec 9, 2015 Dec 10, 2015 Travere Therapeutics, Inc. EVP of Research & Development Sell 37.5 -8,750 -4.53% ✓ $182.3K
Oct 6, 2015 Oct 8, 2015 Travere Therapeutics, Inc. EVP of Research & Development Sell 37.5 -8,750 -4.33% ✓ $176.1K
Jun 26, 2015 Jun 30, 2015 Travere Therapeutics, Inc. EVP of Research & Development Sell 22.5 -27,916 -12.14% ✓ $912.9K